TRIAMCINOLONE DIACETATE SUSPENSION DIN 01977555
Health Canada record
| Active ingredient(s) | TRIAMCINOLONE DIACETATE 40 MG |
|---|---|
| Dosage form | Suspension |
| Route | Intra-Articular; Intramuscular; Intradermal; Intralesional |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H02AB08 TRIAMCINOLONE |
| Original market date | 19-Nov-1992 |
| Current status date | 03-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRIAMCINOLONE DIACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02194120 | ARISTOCORT FORTE - LIQ IA IM ISY 40MG/ML | GLADES, DIVISION OF STIEFEL CANADA INC. | Liquid | TRIAMCINOLONE DIACETATE 40 MG | Cancelled Post Market |
| 00014842 | ARISTOCORT FORTE INJ 40MG/ML | LEDERLE CYANAMID CANADA INC. | Liquid | TRIAMCINOLONE DIACETATE 40 MG | Cancelled Post Market |
| 00014834 | ARISTOCORT INJ INTRALESIONAL 25MG/ML | LEDERLE CYANAMID CANADA INC. | Liquid | TRIAMCINOLONE DIACETATE 25 MG | Cancelled Post Market |
| 02194147 | ARISTOCORT INJ INTRALESIONAL-25MG/ML | GLADES, DIVISION OF STIEFEL CANADA INC. | Liquid | TRIAMCINOLONE DIACETATE 25 MG | Cancelled Post Market |
| 00014893 | ARISTOCORT SYR 2MG/5ML | LEDERLE CYANAMID CANADA INC. | Syrup | TRIAMCINOLONE DIACETATE 2 MG | Cancelled Post Market |
| 00716995 | TRIAMCINOLONE DIACETATE SUS 40MG/ML | TARO PHARMACEUTICALS INC | Suspension | TRIAMCINOLONE DIACETATE 40 MG | Cancelled Post Market |
International API supply for TRIAMCINOLONE DIACETATE
1 active FDA Drug Master Files.
Request a quote for TRIAMCINOLONE DIACETATE SUSPENSION